DEUTSCHE BANK AG\ - CYTOSORBENTS CORP ownership

CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 95 filers reported holding CYTOSORBENTS CORP in Q4 2020. The put-call ratio across all filers is 1.49 and the average weighting 0.1%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of CYTOSORBENTS CORP
ValueSharesWeighting
Q2 2023$63,475
+6.5%
17,6810.0%0.00%
Q1 2023$59,585
+117.4%
17,6810.0%0.00%
Q4 2022$27,406
+14.2%
17,6810.0%0.00%
Q3 2022$24,000
-38.5%
17,6810.0%0.00%
Q2 2022$39,000
-48.7%
17,681
-26.4%
0.00%
Q1 2022$76,000
-46.9%
24,037
-29.5%
0.00%
Q4 2021$143,000
-46.2%
34,095
+4.0%
0.00%
Q3 2021$266,000
+1.9%
32,769
-5.2%
0.00%
Q2 2021$261,000
-15.0%
34,558
-2.3%
0.00%
Q1 2021$307,000
+1.7%
35,374
-6.6%
0.00%
Q4 2020$302,000
+26.9%
37,870
+26.8%
0.00%
Q3 2020$238,000
-68.2%
29,877
-60.4%
0.00%
-100.0%
Q2 2020$748,000
+442.0%
75,496
+325.0%
0.00%
Q1 2020$138,000
+97.1%
17,765
-3.4%
0.00%
Q4 2019$70,000
+62.8%
18,383
+106.9%
0.00%
Q3 2019$43,000
-72.6%
8,886
-62.9%
0.00%
Q2 2019$157,000
-72.8%
23,936
-68.7%
0.00%
Q1 2019$577,000
-55.5%
76,383
-52.4%
0.00%
-100.0%
Q4 2018$1,297,000
-21.1%
160,546
+25.9%
0.00%
Q3 2018$1,643,000
-2.9%
127,493
-14.2%
0.00%
Q2 2018$1,692,000
+209.3%
148,531
+91.1%
0.00%
Q1 2018$547,000
+18133.3%
77,704
+11016.5%
0.00%
Q1 2017$3,000
+50.0%
699
+77.4%
0.00%
Q3 2016$2,000394
+425.3%
0.00%
Q2 2016$075
-15.7%
0.00%
Q1 2016$0
-100.0%
89
-99.1%
0.00%
Q4 2015$56,000
+2700.0%
10,092
+2423.0%
0.00%
Q3 2015$2,000
-90.5%
400
-88.6%
0.00%
Q2 2015$21,000
+250.0%
3,500
+600.0%
0.00%
Q1 2015$6,0005000.00%
Other shareholders
CYTOSORBENTS CORP shareholders Q4 2020
NameSharesValueWeighting ↓
CM Management, LLC 450,000$846,0000.90%
Skylands Capital, LLC 2,944,670$5,535,9800.84%
Sargent Investment Group, LLC 1,257,048$2,363,2500.57%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 197,940$372,1270.52%
Avenir Corp 2,717,397$5,108,7060.48%
Granahan Investment Management 1,552,393$2,918,4990.10%
Seelaus Asset Management LLC 20,450$38,4460.04%
HighMark Wealth Management LLC 10,000$18,8000.02%
Key Client Fiduciary Advisors, LLC 13,000$24,4400.02%
Eudaimonia Partners, LLC 23,500$44,1800.01%
View complete list of CYTOSORBENTS CORP shareholders